Tag: Non hormonal treatment

Up to 80% of menopausal women experience vasomotor symptoms (VMS), such as hot flashes. For those exploring non-hormonal options, a primary concern is: **how long does it take Paxil to work for hot flashes?** This article examines the expected timeline for relief.

On May 12, 2023, the U.S. Food and Drug Administration (FDA) approved Veozah (fezolinetant) as a new prescription medication. This landmark decision provided a non-hormonal treatment option for women experiencing moderate to severe vasomotor symptoms (VMS), also known as hot flashes, due to menopause.

According to clinical studies, some women taking Veozah begin to experience a reduction in hot flashes in as early as one week. This article explores the timeline for how long it takes for Veozah to start working, from initial improvements to the full effect, based on trial data and expert insights.

As many as 80% of women experience vasomotor symptoms (VMS), like hot flashes, during the menopausal transition [1.2.6]. For those exploring options beyond Veozah, understanding 'What can I take instead of Veozah?' involves looking at both hormonal and other non-hormonal treatments.

Roughly 80% of women experience vasomotor symptoms like hot flashes and night sweats during menopause. In response, a significant advancement offers a new treatment for hot flashes: the non-hormonal drug Veozah (fezolinetant), approved by the FDA in 2023. This represents a major breakthrough, particularly for those who cannot or prefer not to use hormone replacement therapy.